Company · CIK 1691082
LB PHARMACEUTICALS INC
| CIK | 1691082 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NY |
| Listed | LBRX (Nasdaq) |
| First annual or quarterly report | 2025-11-06 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294900 | 2026-04-06 | 2026-10-05 | 3 | |
| 333-299235 | 2026-10-01 | 2026-10-01 | 1 | |
| 333-289812 | 2025-08-22 | 2025-09-12 | 4 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-10-05 | EFFECTDeclared effective | 333-294900 | 9999999995-26-003150 |
| 2026-10-01 | S-3ASRShelf registered | 333-299235 | 0001193125-26-410651 |
| 2026-04-14 | EFFECTDeclared effective | 333-294900 | 9999999995-26-001186 |
| 2026-04-06 | S-1Registration filed | 333-294900 | 0001193125-26-143724 |
| 2025-09-12 | 424B4Final prospectus | 333-289812 | 0001193125-25-201757 |
| 2025-09-10 | EFFECTDeclared effective | 333-289812 | 9999999995-25-002913 |
| 2025-09-08 | S-1/AAmendment | 333-289812 | 0001193125-25-197877 |
| 2025-08-22 | S-1Registration filed | 333-289812 | 0001193125-25-186467 |
| 2024-05-20 | DRSDraft made public | 377-07237 | 0000950123-24-005777 |